Nakach Mostafa, Authelin Jean-René, Agut Christophe
Sanofi R&D, 1, Impasse des ateliers, Vitry sur Seine 94403, France.
Sanofi R&D, 1, Impasse des ateliers, Vitry sur Seine 94403, France.
J Pharm Sci. 2017 Jul;106(7):1889-1904. doi: 10.1016/j.xphs.2017.02.036. Epub 2017 Mar 14.
Stirred media milling is the main technology for producing colloidal nanocrystalline suspensions. A number of studies have been reported on the effect of different operating parameters for lab, pilot, and industrial scales. However, typical milling tool box that can be used to support candidate from selection up to phase III clinical supplies can involve different mill configurations. This article describes a parametric study and milling kinetic modelling of the different mills. The impact of active pharmaceutical ingredient (API) type and process parameters on milling kinetics was determined. The milling kinetics were modeled using an empirical model which allows for predicting and simulation of milling kinetics of stirred annular and pin mills. The proposed model was found to accurately fit milling kinetics whatever the API considered, technology employed, and the process parameters used for milling. Moreover, the model was found to be able to ensure the process transfer from one mill to another.
搅拌介质磨是生产胶体纳米晶体悬浮液的主要技术。关于实验室、中试和工业规模不同操作参数的影响,已有多项研究报道。然而,可用于支持从筛选到III期临床供应候选药物的典型研磨工具箱可能涉及不同的磨机配置。本文描述了不同磨机的参数研究和研磨动力学建模。确定了活性药物成分(API)类型和工艺参数对研磨动力学的影响。使用经验模型对研磨动力学进行建模,该模型可预测和模拟搅拌环磨机和针磨机的研磨动力学。结果发现,无论考虑何种API、采用何种技术以及用于研磨的工艺参数如何,所提出的模型都能准确拟合研磨动力学。此外,该模型能够确保工艺从一台磨机转移到另一台磨机。